Eli Lilly has doubled its investment in its new Concord manufacturing facility from $1 billion to $2 billion since ...
This collaboration supports Lilly's earlier commitment to fighting drug-resistant pathogens through Social Impact Venture ...
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...
Eli Lilly and Co. (NYSE: LLY) more than doubled its initial investment pledge for its $2 billion Concord manufacturing campus ...
Ashkenazi has been key to managing the windfall in revenue and wave of investor optimism from Eli Lilly's diabetes injection ...
Eli Lilly released results from a pair of clinical trials on Friday afternoon that showed the capability of its weight-loss ...
Pharmaceutical giant Eli Lilly opened its new Concord, NC, facility on Friday. The company has invested more than $2 billion ...
The planned facility in North Carolina is Novo’s latest multibillion-dollar investment in the manufacturing of weight loss drugs, demand for which continues to outstrip supply.
(RTTNews) - Eli Lilly and Co. (LLY) announced Tuesday a collaboration with OpenAI that will allow Lilly to leverage OpenAI's generative AI to invent novel antimicrobials to treat drug-resistant ...
Governor Roy Coope, Eli Lilly officials and others were on hand as the new $2 billion facility opened on Concord Friday, June ...
Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly, was on a West Coast college tour with his daughter ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Novo Nordisk is investing $4.1bn to ...